======= ANAPC15 ======= == Gene Information == * **Official Symbol**: ANAPC15 * **Official Name**: anaphase promoting complex subunit 15 * **Aliases and Previous Symbols**: N/A * **Entrez ID**: [[https://www.ncbi.nlm.nih.gov/gene/?term=25906|25906]] * **UniProt**: [[https://www.uniprot.org/uniprot/P60006|P60006]] * **Interactions**: [[https://thebiogrid.org/search.php?search=ANAPC15&organism=9606|BioGRID]] * **PubMed articles**: [[https://www.ncbi.nlm.nih.gov/pubmed/?term=gene%20ANAPC15|Open PubMed]] * **OMIM**: [[https://omim.org/entry/614717|Open OMIM]] == Function Summary == * **Entrez Summary**: N/A * **UniProt Summary**: Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. In the complex, plays a role in the release of the mitotic checkpoint complex (MCC) from the APC/C: not required for APC/C activity itself, but promotes the turnover of CDC20 and MCC on the APC/C, thereby participating in the responsiveness of the spindle assembly checkpoint. Also required for degradation of CDC20. {ECO:0000269|PubMed:21926987}. No Pfam Domain information is available for this gene. |regulation of spindle checkpoint| |regulation of mitotic spindle checkpoint| |regulation of mitotic cell cycle spindle assembly checkpoint| |anaphase-promoting complex| |regulation of cell cycle checkpoint| |regulation of mitotic metaphase/anaphase transition| |regulation of metaphase/anaphase transition of cell cycle| |regulation of mitotic sister chromatid separation| |regulation of chromosome separation| |regulation of mitotic sister chromatid segregation| |regulation of sister chromatid segregation| |anaphase-promoting complex-dependent catabolic process| |intracellular| |regulation of chromosome segregation| |regulation of mitotic nuclear division| |regulation of nuclear division| |proteasome-mediated ubiquitin-dependent protein catabolic process| |regulation of chromosome organization| |proteasomal protein catabolic process| |regulation of mitotic cell cycle phase transition| |regulation of cell cycle phase transition| |cell division| |ubiquitin-dependent protein catabolic process| |modification-dependent protein catabolic process| |modification-dependent macromolecule catabolic process| |proteolysis involved in cellular protein catabolic process| |cellular protein catabolic process| |regulation of mitotic cell cycle| |protein catabolic process| |regulation of cell cycle process| |cellular macromolecule catabolic process| |macromolecule catabolic process| |organonitrogen compound catabolic process| |regulation of cell cycle| |proteolysis| |regulation of organelle organization| |cell cycle| |organic substance catabolic process| |cellular catabolic process| \\ === CRISPR Data === ^Screen^Score^ |[[:results:exp177|Apcin 25μM plus proTAME 2μM R04 exp177]]|-3.5| |[[:results:exp242|Radicicol 0.16μM R05 exp242]]|-2.77| |[[:results:exp264|Arsenate 40μM R06 exp264]]|-2.6| |[[:results:exp228|Demecolcine 0.03μM R05 exp228]]|-2.56| |[[:results:exp288|HMS-I2 10μM R06 exp288]]|-2.42| |[[:results:exp59|UMK57 1μM R01 exp59]]|-2.36| |[[:results:exp187|proTAME 5μM R04 exp187]]|-2.34| |[[:results:exp332|Adefovir 20μM R07 exp332]]|-2.28| |[[:results:exp176|Apcin 50 to 100μM on day4 R04 exp176]]|-2.27| |[[:results:exp343|Centrinone 0.5μM R07 exp343]]|-2.26| |[[:results:exp215|Colchicine 0.009μM R05 exp215]]|-2.22| |[[:results:exp179|Combretastatin A4 0.002 to 0.003μM day4 R04 exp179]]|-2.19| |[[:results:exp270|Campthothecin 0.001μM R06 exp270]]|-2.16| |[[:results:exp198|Etoposide 0.1μM R05 exp198]]|-2.15| |[[:results:exp275|Citral 75μM R06 exp275]]|-2.09| |[[:results:exp97|BI-6727 0.0125μM R03 exp97]]|-2.05| |[[:results:exp500|LY2090314 0.003μM R08 exp500 no dilution day6]]|-2.04| |[[:results:exp292|Menadione 5μM R06 exp292]]|-1.99| |[[:results:exp60|Vinblastine 0.002μM R01 exp60]]|-1.98| |[[:results:exp72|LB-100 4.1μM R02 exp72]]|-1.94| |[[:results:exp299|Talazoparib 0.006μM R06 exp299]]|-1.93| |[[:results:exp271|CCT251545 0.2μM R06 exp271]]|-1.92| |[[:results:exp274|Citral 50μM R06 exp274]]|-1.85| |[[:results:exp291|LLY-284 2.6μM R06 exp291]]|-1.85| |[[:results:exp520|Rucaparib 6.5μM R08 exp520]]|-1.82| |[[:results:exp440|Aphidicolin 0.4μM R08 exp440]]|-1.73| |[[:results:exp165|RO-3306 3 to 4μM on day4 R04 exp165]]|-1.7| |[[:results:exp101|Nicotinamide 1000μM R03 exp101]]|1.8| ^Gene^Correlation^ |[[:human genes:a:anapc13|ANAPC13]]|0.431| |[[:human genes:u:ube2c|UBE2C]]|0.43| |[[:human genes:s:sgol1|SGOL1]]|0.424| |[[:human genes:u:ube2s|UBE2S]]|0.415| Global Fraction of Cell Lines Where Essential: 180/739 ^Tissue^Fraction Of Cell Lines Where Essential^ |1290807.0|1/1| |909776.0|1/1| |bile duct|5/28| |blood|10/28| |bone|11/26| |breast|10/33| |central nervous system|13/56| |cervix|1/4| |colorectal|1/17| |esophagus|4/13| |fibroblast|1/1| |gastric|2/16| |kidney|7/21| |liver|6/20| |lung|28/75| |lymphocyte|6/16| |ovary|8/26| |pancreas|4/24| |peripheral nervous system|2/16| |plasma cell|3/15| |prostate|0/1| |skin|4/24| |soft tissue|2/9| |thyroid|0/2| |upper aerodigestive|5/22| |urinary tract|6/29| |uterus|3/5| == Essentiality in NALM6 == * **Essentiality Rank**: 3163 * **Expression level (log2 read counts)**: 5.21 {{:chemogenomics:nalm6 dist.png?nolink |}}